|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 26-MAR-2016 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | 4.8 - 5.9 | % |
| Glucose [Mass/volume] in Blood | 67.2 L | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 11.1 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.9 | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.9 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 143.6 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.7 | 3.5 - 5.3 | mmol/L |
| Chloride [Moles/volume] in Blood | 110.3 H | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 23.5 | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 180.9 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 109.1 | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 128.9 H | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 30.2 L | 40 - 60 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 5.0 | 0 - 30 | mg/g |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows mild hypoglycemia, elevated chloride, high LDL cholesterol, and low HDL cholesterol. Renal function and microalbumin/creatinine ratio are normal. The lipid profile indicates increased cardiovascular risk. No evidence of significant renal impairment or diabetes. Recommend clinical correlation for hypoglycemia and consideration of lipid-lowering therapy. |